Robert W. Fairbairn, Director at BlackRock Science & Technology Trust II (BSTZ), bought 13,670 shares at $36.33 ($497K) on 2020-12-29, disclosed to the SEC on 2022-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.33 | 6,835 | $248K | 50.0% |
| 2 | $36.33 | 6,835 | $248K | 50.0% |
| Total | $36.33 avg | 13,670 | $497K | 100% |
| Filing → |
| BMEZ | SELL | 2025-12-22 | $308K | — | Filing → |
| BSTZ | SELL | 2025-12-22 | $418K | — | Filing → |
| ECAT | BUY | 2022-05-13 | $1.2M | — | Filing → |